Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurology Clinical Trial Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Bone Marrow
1.2.3 Epidermis
1.2.4 Mesenchymal Stem Cells
1.2.5 Haematopoietic Stem Cells
1.2.6 Chondrocytes
1.3 Market by Application
1.3.1 Global Neurology Clinical Trial Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Neurodegenerative Disorders
1.3.3 Cardiovascular Disorders
1.3.4 Orthopedics
1.3.5 Wound Healing
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neurology Clinical Trial Market Perspective (2018-2033)
2.2 Global Neurology Clinical Trial Growth Trends by Region
2.2.1 Neurology Clinical Trial Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neurology Clinical Trial Historic Market Size by Region (2018-2023)
2.2.3 Neurology Clinical Trial Forecasted Market Size by Region (2024-2033)
2.3 Neurology Clinical Trial Market Dynamics
2.3.1 Neurology Clinical Trial Industry Trends
2.3.2 Neurology Clinical Trial Market Drivers
2.3.3 Neurology Clinical Trial Market Challenges
2.3.4 Neurology Clinical Trial Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neurology Clinical Trial by Players
3.1.1 Global Neurology Clinical Trial Revenue by Players (2018-2023)
3.1.2 Global Neurology Clinical Trial Revenue Market Share by Players (2018-2023)
3.2 Global Neurology Clinical Trial Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neurology Clinical Trial, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Neurology Clinical Trial Market Concentration Ratio
3.4.1 Global Neurology Clinical Trial Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurology Clinical Trial Revenue in 2022
3.5 Global Key Players of Neurology Clinical Trial Head office and Area Served
3.6 Global Key Players of Neurology Clinical Trial, Product and Application
3.7 Global Key Players of Neurology Clinical Trial, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurology Clinical Trial Breakdown Data by Type
4.1 Global Neurology Clinical Trial Historic Market Size by Type (2018-2023)
4.2 Global Neurology Clinical Trial Forecasted Market Size by Type (2024-2033)
5 Neurology Clinical Trial Breakdown Data by Application
5.1 Global Neurology Clinical Trial Historic Market Size by Application (2018-2023)
5.2 Global Neurology Clinical Trial Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neurology Clinical Trial Market Size (2018-2033)
6.2 North America Neurology Clinical Trial Market Size by Type
6.2.1 North America Neurology Clinical Trial Market Size by Type (2018-2023)
6.2.2 North America Neurology Clinical Trial Market Size by Type (2024-2033)
6.2.3 North America Neurology Clinical Trial Market Share by Type (2018-2033)
6.3 North America Neurology Clinical Trial Market Size by Application
6.3.1 North America Neurology Clinical Trial Market Size by Application (2018-2023)
6.3.2 North America Neurology Clinical Trial Market Size by Application (2024-2033)
6.3.3 North America Neurology Clinical Trial Market Share by Application (2018-2033)
6.4 North America Neurology Clinical Trial Market Size by Country
6.4.1 North America Neurology Clinical Trial Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Neurology Clinical Trial Market Size by Country (2018-2023)
6.4.3 North America Neurology Clinical Trial Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Neurology Clinical Trial Market Size (2018-2033)
7.2 Europe Neurology Clinical Trial Market Size by Type
7.2.1 Europe Neurology Clinical Trial Market Size by Type (2018-2023)
7.2.2 Europe Neurology Clinical Trial Market Size by Type (2024-2033)
7.2.3 Europe Neurology Clinical Trial Market Share by Type (2018-2033)
7.3 Europe Neurology Clinical Trial Market Size by Application
7.3.1 Europe Neurology Clinical Trial Market Size by Application (2018-2023)
7.3.2 Europe Neurology Clinical Trial Market Size by Application (2024-2033)
7.3.3 Europe Neurology Clinical Trial Market Share by Application (2018-2033)
7.4 Europe Neurology Clinical Trial Market Size by Country
7.4.1 Europe Neurology Clinical Trial Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Neurology Clinical Trial Market Size by Country (2018-2023)
7.4.3 Europe Neurology Clinical Trial Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neurology Clinical Trial Market Size (2018-2033)
8.2 China Neurology Clinical Trial Market Size by Type
8.2.1 China Neurology Clinical Trial Market Size by Type (2018-2023)
8.2.2 China Neurology Clinical Trial Market Size by Type (2024-2033)
8.2.3 China Neurology Clinical Trial Market Share by Type (2018-2033)
8.3 China Neurology Clinical Trial Market Size by Application
8.3.1 China Neurology Clinical Trial Market Size by Application (2018-2023)
8.3.2 China Neurology Clinical Trial Market Size by Application (2024-2033)
8.3.3 China Neurology Clinical Trial Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Neurology Clinical Trial Market Size (2018-2033)
9.2 Asia Neurology Clinical Trial Market Size by Type
9.2.1 Asia Neurology Clinical Trial Market Size by Type (2018-2023)
9.2.2 Asia Neurology Clinical Trial Market Size by Type (2024-2033)
9.2.3 Asia Neurology Clinical Trial Market Share by Type (2018-2033)
9.3 Asia Neurology Clinical Trial Market Size by Application
9.3.1 Asia Neurology Clinical Trial Market Size by Application (2018-2023)
9.3.2 Asia Neurology Clinical Trial Market Size by Application (2024-2033)
9.3.3 Asia Neurology Clinical Trial Market Share by Application (2018-2033)
9.4 Asia Neurology Clinical Trial Market Size by Region
9.4.1 Asia Neurology Clinical Trial Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Neurology Clinical Trial Market Size by Region (2018-2023)
9.4.3 Asia Neurology Clinical Trial Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Neurology Clinical Trial Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Neurology Clinical Trial Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BrainStorm Cell Therapeutics
11.1.1 BrainStorm Cell Therapeutics Company Details
11.1.2 BrainStorm Cell Therapeutics Business Overview
11.1.3 BrainStorm Cell Therapeutics Neurology Clinical Trial Introduction
11.1.4 BrainStorm Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.1.5 BrainStorm Cell Therapeutics Recent Developments
11.2 Opexa Therapeutics
11.2.1 Opexa Therapeutics Company Details
11.2.2 Opexa Therapeutics Business Overview
11.2.3 Opexa Therapeutics Neurology Clinical Trial Introduction
11.2.4 Opexa Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.2.5 Opexa Therapeutics Recent Developments
11.3 Caladrius Biosciences
11.3.1 Caladrius Biosciences Company Details
11.3.2 Caladrius Biosciences Business Overview
11.3.3 Caladrius Biosciences Neurology Clinical Trial Introduction
11.3.4 Caladrius Biosciences Revenue in Neurology Clinical Trial Business (2018-2023)
11.3.5 Caladrius Biosciences Recent Developments
11.4 U.S. Stem Cell
11.4.1 U.S. Stem Cell Company Details
11.4.2 U.S. Stem Cell Business Overview
11.4.3 U.S. Stem Cell Neurology Clinical Trial Introduction
11.4.4 U.S. Stem Cell Revenue in Neurology Clinical Trial Business (2018-2023)
11.4.5 U.S. Stem Cell Recent Developments
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Neurology Clinical Trial Introduction
11.5.4 Lonza Revenue in Neurology Clinical Trial Business (2018-2023)
11.5.5 Lonza Recent Developments
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Neurology Clinical Trial Introduction
11.6.4 Bristol Myers Squibb Revenue in Neurology Clinical Trial Business (2018-2023)
11.6.5 Bristol Myers Squibb Recent Developments
11.7 Corning Incorporated
11.7.1 Corning Incorporated Company Details
11.7.2 Corning Incorporated Business Overview
11.7.3 Corning Incorporated Neurology Clinical Trial Introduction
11.7.4 Corning Incorporated Revenue in Neurology Clinical Trial Business (2018-2023)
11.7.5 Corning Incorporated Recent Developments
11.8 Vericel Corporation
11.8.1 Vericel Corporation Company Details
11.8.2 Vericel Corporation Business Overview
11.8.3 Vericel Corporation Neurology Clinical Trial Introduction
11.8.4 Vericel Corporation Revenue in Neurology Clinical Trial Business (2018-2023)
11.8.5 Vericel Corporation Recent Developments
11.9 Catalent
11.9.1 Catalent Company Details
11.9.2 Catalent Business Overview
11.9.3 Catalent Neurology Clinical Trial Introduction
11.9.4 Catalent Revenue in Neurology Clinical Trial Business (2018-2023)
11.9.5 Catalent Recent Developments
11.10 Lineage Cell Therapeutics
11.10.1 Lineage Cell Therapeutics Company Details
11.10.2 Lineage Cell Therapeutics Business Overview
11.10.3 Lineage Cell Therapeutics Neurology Clinical Trial Introduction
11.10.4 Lineage Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.10.5 Lineage Cell Therapeutics Recent Developments
11.11 Castle Creek Biosciences
11.11.1 Castle Creek Biosciences Company Details
11.11.2 Castle Creek Biosciences Business Overview
11.11.3 Castle Creek Biosciences Neurology Clinical Trial Introduction
11.11.4 Castle Creek Biosciences Revenue in Neurology Clinical Trial Business (2018-2023)
11.11.5 Castle Creek Biosciences Recent Developments
11.12 Sangamo Therapeutics
11.12.1 Sangamo Therapeutics Company Details
11.12.2 Sangamo Therapeutics Business Overview
11.12.3 Sangamo Therapeutics Neurology Clinical Trial Introduction
11.12.4 Sangamo Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.12.5 Sangamo Therapeutics Recent Developments
11.13 Novartis
11.13.1 Novartis Company Details
11.13.2 Novartis Business Overview
11.13.3 Novartis Neurology Clinical Trial Introduction
11.13.4 Novartis Revenue in Neurology Clinical Trial Business (2018-2023)
11.13.5 Novartis Recent Developments
11.14 Holostem Terapie Avanzate S.R.L
11.14.1 Holostem Terapie Avanzate S.R.L Company Details
11.14.2 Holostem Terapie Avanzate S.R.L Business Overview
11.14.3 Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Introduction
11.14.4 Holostem Terapie Avanzate S.R.L Revenue in Neurology Clinical Trial Business (2018-2023)
11.14.5 Holostem Terapie Avanzate S.R.L Recent Developments
11.15 Pharmicell
11.15.1 Pharmicell Company Details
11.15.2 Pharmicell Business Overview
11.15.3 Pharmicell Neurology Clinical Trial Introduction
11.15.4 Pharmicell Revenue in Neurology Clinical Trial Business (2018-2023)
11.15.5 Pharmicell Recent Developments
11.16 Tego Science
11.16.1 Tego Science Company Details
11.16.2 Tego Science Business Overview
11.16.3 Tego Science Neurology Clinical Trial Introduction
11.16.4 Tego Science Revenue in Neurology Clinical Trial Business (2018-2023)
11.16.5 Tego Science Recent Developments
11.17 Autolus therapeutics
11.17.1 Autolus therapeutics Company Details
11.17.2 Autolus therapeutics Business Overview
11.17.3 Autolus therapeutics Neurology Clinical Trial Introduction
11.17.4 Autolus therapeutics Revenue in Neurology Clinical Trial Business (2018-2023)
11.17.5 Autolus therapeutics Recent Developments
11.18 Bayer AG
11.18.1 Bayer AG Company Details
11.18.2 Bayer AG Business Overview
11.18.3 Bayer AG Neurology Clinical Trial Introduction
11.18.4 Bayer AG Revenue in Neurology Clinical Trial Business (2018-2023)
11.18.5 Bayer AG Recent Developments
11.19 Sartorius AG
11.19.1 Sartorius AG Company Details
11.19.2 Sartorius AG Business Overview
11.19.3 Sartorius AG Neurology Clinical Trial Introduction
11.19.4 Sartorius AG Revenue in Neurology Clinical Trial Business (2018-2023)
11.19.5 Sartorius AG Recent Developments
11.20 Daiichi Sankyo
11.20.1 Daiichi Sankyo Company Details
11.20.2 Daiichi Sankyo Business Overview
11.20.3 Daiichi Sankyo Neurology Clinical Trial Introduction
11.20.4 Daiichi Sankyo Revenue in Neurology Clinical Trial Business (2018-2023)
11.20.5 Daiichi Sankyo Recent Developments
11.21 Takeda Pharmaceutical Company
11.21.1 Takeda Pharmaceutical Company Company Details
11.21.2 Takeda Pharmaceutical Company Business Overview
11.21.3 Takeda Pharmaceutical Company Neurology Clinical Trial Introduction
11.21.4 Takeda Pharmaceutical Company Revenue in Neurology Clinical Trial Business (2018-2023)
11.21.5 Takeda Pharmaceutical Company Recent Developments
11.22 Sumitomo Chemical Co
11.22.1 Sumitomo Chemical Co Company Details
11.22.2 Sumitomo Chemical Co Business Overview
11.22.3 Sumitomo Chemical Co Neurology Clinical Trial Introduction
11.22.4 Sumitomo Chemical Co Revenue in Neurology Clinical Trial Business (2018-2023)
11.22.5 Sumitomo Chemical Co Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neurology Clinical Trial Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Bone Marrow
Table 3. Key Players of Epidermis
Table 4. Key Players of Mesenchymal Stem Cells
Table 5. Key Players of Haematopoietic Stem Cells
Table 6. Key Players of Chondrocytes
Table 7. Global Neurology Clinical Trial Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global Neurology Clinical Trial Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Neurology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Neurology Clinical Trial Market Share by Region (2018-2023)
Table 11. Global Neurology Clinical Trial Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Neurology Clinical Trial Market Share by Region (2024-2033)
Table 13. Neurology Clinical Trial Market Trends
Table 14. Neurology Clinical Trial Market Drivers
Table 15. Neurology Clinical Trial Market Challenges
Table 16. Neurology Clinical Trial Market Restraints
Table 17. Global Neurology Clinical Trial Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Neurology Clinical Trial Revenue Share by Players (2018-2023)
Table 19. Global Top Neurology Clinical Trial by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2022)
Table 20. Global Neurology Clinical Trial Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Neurology Clinical Trial Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Neurology Clinical Trial, Headquarters and Area Served
Table 23. Global Key Players of Neurology Clinical Trial, Product and Application
Table 24. Global Key Players of Neurology Clinical Trial, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Neurology Clinical Trial Revenue Market Share by Type (2018-2023)
Table 28. Global Neurology Clinical Trial Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Neurology Clinical Trial Revenue Market Share by Type (2024-2033)
Table 30. Global Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Neurology Clinical Trial Revenue Share by Application (2018-2023)
Table 32. Global Neurology Clinical Trial Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Neurology Clinical Trial Revenue Share by Application (2024-2033)
Table 34. North America Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Neurology Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Neurology Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Neurology Clinical Trial Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Neurology Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Neurology Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Neurology Clinical Trial Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Neurology Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Neurology Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Neurology Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Neurology Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Neurology Clinical Trial Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia Neurology Clinical Trial Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Neurology Clinical Trial Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Neurology Clinical Trial Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Neurology Clinical Trial Market Size by Country (2024-2033) & (US$ Million)
Table 66. BrainStorm Cell Therapeutics Company Details
Table 67. BrainStorm Cell Therapeutics Business Overview
Table 68. BrainStorm Cell Therapeutics Neurology Clinical Trial Product
Table 69. BrainStorm Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 70. BrainStorm Cell Therapeutics Recent Developments
Table 71. Opexa Therapeutics Company Details
Table 72. Opexa Therapeutics Business Overview
Table 73. Opexa Therapeutics Neurology Clinical Trial Product
Table 74. Opexa Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 75. Opexa Therapeutics Recent Developments
Table 76. Caladrius Biosciences Company Details
Table 77. Caladrius Biosciences Business Overview
Table 78. Caladrius Biosciences Neurology Clinical Trial Product
Table 79. Caladrius Biosciences Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 80. Caladrius Biosciences Recent Developments
Table 81. U.S. Stem Cell Company Details
Table 82. U.S. Stem Cell Business Overview
Table 83. U.S. Stem Cell Neurology Clinical Trial Product
Table 84. U.S. Stem Cell Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 85. U.S. Stem Cell Recent Developments
Table 86. Lonza Company Details
Table 87. Lonza Business Overview
Table 88. Lonza Neurology Clinical Trial Product
Table 89. Lonza Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 90. Lonza Recent Developments
Table 91. Bristol Myers Squibb Company Details
Table 92. Bristol Myers Squibb Business Overview
Table 93. Bristol Myers Squibb Neurology Clinical Trial Product
Table 94. Bristol Myers Squibb Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 95. Bristol Myers Squibb Recent Developments
Table 96. Corning Incorporated Company Details
Table 97. Corning Incorporated Business Overview
Table 98. Corning Incorporated Neurology Clinical Trial Product
Table 99. Corning Incorporated Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 100. Corning Incorporated Recent Developments
Table 101. Vericel Corporation Company Details
Table 102. Vericel Corporation Business Overview
Table 103. Vericel Corporation Neurology Clinical Trial Product
Table 104. Vericel Corporation Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 105. Vericel Corporation Recent Developments
Table 106. Catalent Company Details
Table 107. Catalent Business Overview
Table 108. Catalent Neurology Clinical Trial Product
Table 109. Catalent Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 110. Catalent Recent Developments
Table 111. Lineage Cell Therapeutics Company Details
Table 112. Lineage Cell Therapeutics Business Overview
Table 113. Lineage Cell Therapeutics Neurology Clinical Trial Product
Table 114. Lineage Cell Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 115. Lineage Cell Therapeutics Recent Developments
Table 116. Castle Creek Biosciences Company Details
Table 117. Castle Creek Biosciences Business Overview
Table 118. Castle Creek Biosciences Neurology Clinical Trial Product
Table 119. Castle Creek Biosciences Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 120. Castle Creek Biosciences Recent Developments
Table 121. Sangamo Therapeutics Company Details
Table 122. Sangamo Therapeutics Business Overview
Table 123. Sangamo Therapeutics Neurology Clinical Trial Product
Table 124. Sangamo Therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 125. Sangamo Therapeutics Recent Developments
Table 126. Novartis Company Details
Table 127. Novartis Business Overview
Table 128. Novartis Neurology Clinical Trial Product
Table 129. Novartis Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 130. Novartis Recent Developments
Table 131. Holostem Terapie Avanzate S.R.L Company Details
Table 132. Holostem Terapie Avanzate S.R.L Business Overview
Table 133. Holostem Terapie Avanzate S.R.L Neurology Clinical Trial Product
Table 134. Holostem Terapie Avanzate S.R.L Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 135. Holostem Terapie Avanzate S.R.L Recent Developments
Table 136. Pharmicell Company Details
Table 137. Pharmicell Business Overview
Table 138. Pharmicell Neurology Clinical Trial Product
Table 139. Pharmicell Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 140. Pharmicell Recent Developments
Table 141. Tego Science Company Details
Table 142. Tego Science Business Overview
Table 143. Tego Science Neurology Clinical Trial Product
Table 144. Tego Science Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 145. Tego Science Recent Developments
Table 146. Autolus therapeutics Company Details
Table 147. Autolus therapeutics Business Overview
Table 148. Autolus therapeutics Neurology Clinical Trial Product
Table 149. Autolus therapeutics Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 150. Autolus therapeutics Recent Developments
Table 151. Bayer AG Company Details
Table 152. Bayer AG Business Overview
Table 153. Bayer AG Neurology Clinical Trial Product
Table 154. Bayer AG Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 155. Bayer AG Recent Developments
Table 156. Sartorius AG Company Details
Table 157. Sartorius AG Business Overview
Table 158. Sartorius AG Neurology Clinical Trial Product
Table 159. Sartorius AG Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 160. Sartorius AG Recent Developments
Table 161. Daiichi Sankyo Company Details
Table 162. Daiichi Sankyo Business Overview
Table 163. Daiichi Sankyo Neurology Clinical Trial Product
Table 164. Daiichi Sankyo Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 165. Daiichi Sankyo Recent Developments
Table 166. Takeda Pharmaceutical Company Company Details
Table 167. Takeda Pharmaceutical Company Business Overview
Table 168. Takeda Pharmaceutical Company Neurology Clinical Trial Product
Table 169. Takeda Pharmaceutical Company Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 170. Takeda Pharmaceutical Company Recent Developments
Table 171. Sumitomo Chemical Co Company Details
Table 172. Sumitomo Chemical Co Business Overview
Table 173. Sumitomo Chemical Co Neurology Clinical Trial Product
Table 174. Sumitomo Chemical Co Revenue in Neurology Clinical Trial Business (2018-2023) & (US$ Million)
Table 175. Sumitomo Chemical Co Recent Developments
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurology Clinical Trial Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Neurology Clinical Trial Market Share by Type: 2022 VS 2033
Figure 3. Bone Marrow Features
Figure 4. Epidermis Features
Figure 5. Mesenchymal Stem Cells Features
Figure 6. Haematopoietic Stem Cells Features
Figure 7. Chondrocytes Features
Figure 8. Global Neurology Clinical Trial Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global Neurology Clinical Trial Market Share by Application: 2022 VS 2033
Figure 10. Neurodegenerative Disorders Case Studies
Figure 11. Cardiovascular Disorders Case Studies
Figure 12. Orthopedics Case Studies
Figure 13. Wound Healing Case Studies
Figure 14. Other Case Studies
Figure 15. Neurology Clinical Trial Report Years Considered
Figure 16. Global Neurology Clinical Trial Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Neurology Clinical Trial Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Neurology Clinical Trial Market Share by Region: 2022 VS 2033
Figure 19. Global Neurology Clinical Trial Market Share by Players in 2022
Figure 20. Global Top Neurology Clinical Trial Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurology Clinical Trial as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Neurology Clinical Trial Revenue in 2022
Figure 22. North America Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Neurology Clinical Trial Market Share by Type (2018-2033)
Figure 24. North America Neurology Clinical Trial Market Share by Application (2018-2033)
Figure 25. North America Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 26. United States Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Neurology Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe Neurology Clinical Trial Market Share by Type (2018-2033)
Figure 30. Europe Neurology Clinical Trial Market Share by Application (2018-2033)
Figure 31. Europe Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 32. Germany Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China Neurology Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China Neurology Clinical Trial Market Share by Type (2018-2033)
Figure 40. China Neurology Clinical Trial Market Share by Application (2018-2033)
Figure 41. Asia Neurology Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia Neurology Clinical Trial Market Share by Type (2018-2033)
Figure 43. Asia Neurology Clinical Trial Market Share by Application (2018-2033)
Figure 44. Asia Neurology Clinical Trial Market Share by Region (2018-2033)
Figure 45. Japan Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Neurology Clinical Trial Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Neurology Clinical Trial Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America Neurology Clinical Trial Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America Neurology Clinical Trial Market Share by Country (2018-2033)
Figure 55. Brazil Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries Neurology Clinical Trial Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. BrainStorm Cell Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 62. Opexa Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 63. Caladrius Biosciences Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 64. U.S. Stem Cell Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 65. Lonza Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 66. Bristol Myers Squibb Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 67. Corning Incorporated Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 68. Vericel Corporation Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 69. Catalent Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 70. Lineage Cell Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 71. Castle Creek Biosciences Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 72. Sangamo Therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 73. Novartis Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 74. Holostem Terapie Avanzate S.R.L Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 75. Pharmicell Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 76. Tego Science Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 77. Autolus therapeutics Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 78. Bayer AG Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 79. Sartorius AG Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 80. Daiichi Sankyo Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 81. Takeda Pharmaceutical Company Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 82. Sumitomo Chemical Co Revenue Growth Rate in Neurology Clinical Trial Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed